Story · Medicine & Biotech

Moderna’s $94 Billion Valuation: A 36-Times-Sales Bet on Cancer Vaccines—or Another Wall Street Mirage?

1 outlet · first reported by TrialSite News on

Moderna’s $94 Billion Valuation: A 36-Times-Sales Bet on Cancer Vaccines—or Another Wall Street Mirage? (TrialSite News)

Coverage, in order

  1. TrialSite News obscure
    Moderna’s $94 Billion Valuation: A 36-Times-Sales Bet on Cancer Vaccines—or Another Wall Street Mirage?

    Moderna’s $94 Billion Valuation: A 36-Times-Sales Bet on Cancer Vaccines—or Another Wall Street Mirage?

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.